Clinical Trials for Stomach Cancer

Find clinical trials for stomach cancer. Discover research opportunities and treatment options in your area.

24 Active Trials Found

Showing 24 trials on this page

Page 1 of 2

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

NCT ID: NCT06199895

This clinical trial is studying a new treatment called Paclitaxel Polymeric Micelles for Injection. It aims to help patients with advanced cancers, including pancreatic, bile duct, lung, stomach, e...

Recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei, China

Brodalumab in the Treatment of Immune-Related Adverse Events

NCT ID: NCT06673329

This clinical trial is studying a medication called brodalumab to see if it can help manage side effects caused by cancer treatments that boost the immune system. These side effects, known as immun...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

NCT ID: NCT06263088

The EQUITY GI clinical trial is designed to improve the care of Black patients diagnosed with various types of gastrointestinal (GI) cancers, such as colon, rectal, pancreatic, and stomach cancer. ...

Recruiting

Phase: NA Type: interventional Locations: Cleveland, Ohio, United States

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

NCT ID: NCT06028737

This clinical trial is looking at the best way to treat patients with locally advanced gastric cancer, which is a type of stomach cancer that has not yet spread to distant parts of the body. The tr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Kyiv, , Ukraine, Vilnius, , Lithuania

Study of CEA Targeting CAR-T in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

NCT ID: NCT06821048

This clinical trial is studying a new treatment called CAR-T therapy, which uses specially modified immune cells to target and fight certain types of advanced cancers that are positive for a protei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

NCT ID: NCT05187182

This clinical trial is studying a new treatment called CA-4948, combined with standard chemotherapy and immunotherapy, for patients with advanced gastric and esophageal cancers that cannot be surgi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States

Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type

NCT ID: NCT04890171

This clinical trial is comparing two treatment options for early gastric cancer (stomach cancer) that has a specific type of cells called undifferentiated type. The main goal is to see if a less in...

Recruiting

Phase: NA Type: interventional Locations: Goyang, Gyeonggi, Korea, Republic Of

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

NCT ID: NCT01048281

This clinical trial is focused on understanding the biology of upper gastrointestinal cancers, specifically stomach and esophageal cancers. Researchers are studying tissue samples and cells from pa...

Recruiting

Type: observational Locations: Stanford, California, United States

Target-specific immunoPET Imaging of Digestive System Carcinoma

NCT ID: NCT06715839

This clinical trial is studying a new imaging technique called target-specific immunoPET/CT to help doctors better see and understand digestive system cancers, including liver, stomach, colon, and ...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer

NCT ID: NCT06532799

This clinical trial is investigating a new treatment approach for patients with advanced or metastatic stomach and esophageal cancers that have not responded to standard therapies. The study combin...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT ID: NCT04907643

This clinical trial is exploring how virtual reality (VR) can help manage severe abdominal pain in patients with digestive tract cancers. The study aims to find out if using immersive VR—where pati...

Recruiting

Phase: NA Type: interventional Locations: Los Angeles, California, United States

Avutometinib and Defactinib in Diffuse Gastric Cancer

NCT ID: NCT06487221

This clinical trial is looking at a new treatment for patients with diffuse-type gastric cancer, which is a type of stomach cancer. Researchers want to see if a combination of two drugs, avutometin...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States

Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment

NCT ID: NCT06653478

This clinical trial focuses on using advanced technology, specifically artificial intelligence, to improve how doctors predict the risk of different types of cancer, including lung, stomach, and co...

Recruiting

Type: observational Locations: Wuhan, Hubei, China

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

NCT ID: NCT06582849

This clinical trial is exploring how providing extra support can help patients with certain cancers complete their radiotherapy treatments without delays. Radiotherapy is a common treatment that us...

Recruiting

Phase: NA Type: interventional Locations: Saint Louis, Missouri, United States

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

NCT ID: NCT04825834

The DELFI-L101 Study is a clinical trial aimed at improving the early detection of lung cancer by testing a special method called the DELFI assay. The goal is to train and evaluate tools that can h...

Recruiting

Type: observational Locations: New York, New York, United States, Cleveland, Ohio, United States

Cancer Loyalty Card Study 2 (CLOCS-2)

NCT ID: NCT06447064

The Cancer Loyalty Card Study 2 (CLOCS-2) is a research trial focused on improving early diagnosis of certain types of cancer, including pancreatic, colon, and ovarian cancers, among others. The st...

Recruiting

Type: observational Locations: London, , United Kingdom

Postoperative Morbidity and Mortality After Gastric Cancer Surgery

NCT ID: NCT06277908

This clinical trial is focused on understanding the outcomes of surgery for gastric cancer, specifically looking at the complications and risks that patients may face after their surgery. Gastric c...

Not yet recruiting

Type: observational Locations: Moscow, , Russian Federation, Moscow, , Russian Federation +7 more

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

NCT ID: NCT05366881

This clinical trial is looking at a new way to detect different types of cancer early and to check if there is any remaining cancer after treatment. Researchers are using a special test that examin...

Recruiting

Type: observational Locations: Rochester, Minnesota, United States, Duarte, California, United States +16 more

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

NCT ID: NCT05415475

This clinical trial is exploring a new treatment called CAR-T cell therapy for patients with advanced cancers that are positive for a marker called CEA. The trial is specifically looking at patient...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China, Jinan, Shandong, China +1 more

KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

NCT ID: NCT05427383

This clinical trial, titled "KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy," is researching a new treatment option for adults wi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions